You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Healthcare Realty reported normalized FFO of $0.42 per share, same-store cash NOI growth of 5.1%, same-store occupancy of 93.1%, and cash leasing spreads of 8.6%. It raised full-year normalized FFO guidance to $1.65 to $1.67 and same-store cash NOI growth guidance to 5% to 5.25%.
Healthcare Realty Trust reported diluted Normalized FFO per share of $1.25 for the nine months ended September 30, 2026, versus $1.20 in 2025; operating cash flow was $317.3 million, and portfolio occupancy was 91.2%.
Healthcare Realty Trust Incorporated raised 2026 Normalized FFO guidance to $1.65 to $1.67 per share and Same Store Cash NOI growth guidance to 5.00% to 5.25%. Third-quarter Normalized FFO was $0.42 per share, and the Board approved a $0.24 per share dividend.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| % of Cash NOI in Company's Top 20 Markets | 77% | Q2 2026 | — |
| Adjusted EBITDA non-GAAP | $184.53M | 2Q 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income (loss) -43.96M
+45.15M Interest expense
+298K Income taxes
+128.07M Depreciation and amortization
+7.26M Unconsolidated JV depreciation, amortization, and interest
+1.47M Transaction costs
-3.71M Gain on sales of assets
+42.74M Impairments on real estate assets
+3.02M Restructuring and severance-related charges
+1.78M Debt financing costs
-7K Timing impact
+4.42M Stock based compensation
+202K Other
-2.19M Unconsolidated JV adjustments
= Adjusted EBITDA 184.53M
|
|||
| Annualized Adjusted EBITDA non-GAAP | $738.13M | 2Q 2026 | — |
| Average annual escalators | 3% | Q2 2026 | — |
| Cash leasing spreads | 4.8% | Q2 2026 | — |
| Cash NOI | $169.89M | 2Q 2026 | — |
| FAD non-GAAP | 109.4M | Q2 2026 | — |
| FAD payout ratio non-GAAP | 76% | Q2 2026 | — |
| FFO attributable to common stockholders non-GAAP | $126.14M | the three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net loss attributable to common stockholders -43.51M
-3.71M Gain on sales of real estate properties
+42.74M Impairment of real estate properties
+126.96M Real estate depreciation and amortization
-537K Non-controlling loss from operating partnership units
+4.21M Unconsolidated JV depreciation and amortization
= FFO attributable to common stockholders 126.14M
|
|||
| FFO attributable to common stockholders per common share - diluted non-GAAP | $0.36 | the three months ended June 30, 2026 filing | — |
| FFO weighted average common shares outstanding - diluted non-GAAP | 347.16M | the three months ended June 30, 2026 filing | — |
| Fully Diluted Shares and Units | 346.96M | 2Q 2026 | — |
| Leverage ratio | 39% | 2Q 2026 | — |
| Liquidity | 1.6B | as of June 30, 2026 | — |
| Maintenance Capital Expenditures | -$27.05M | 2Q 2026 | — |
| NAREIT FFO | 126.14M | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net loss attributable to common stockholders -43.51M
-3.71M Gain on sales of real estate assets
+42.74M Impairments of real estate assets
+126.96M Real estate depreciation and amortization
-537K Non-controlling loss from operating partnership units
+4.21M Unconsolidated JV depreciation, amortization, gain and impairment
= NAREIT FFO 126.14M
|
|||
| NAREIT FFO per common share - diluted non-GAAP | $0.36 | second quarter ended | — |
| NAREIT FFO, diluted non-GAAP | 126.14M | second quarter ended | — |
| Net Debt to Enterprise Value non-GAAP | 37% | Q2 2026 | — |
| New lease executions | 350,000 | Q2 2026 | — |
| Normalized FFO non-GAAP | 143.7M | second quarter ended | — |
GAAP → non-GAAP reconciliationGAAP NAREIT FFO 126.14M
+1.47M Transaction costs
+1.78M Debt financing costs
+3.02M Restructuring and severance-related charges
+10.15M Merger-related fair value adjustment
+1.14M Other
= Normalized FFO 143.7M
|
|||
| Normalized FFO attributable to common stockholders non-GAAP | $143.7M | the three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP FFO attributable to common stockholders 126.14M
+1.47M Transaction costs
+1.78M Debt financing costs
+3.02M Restructuring and severance-related charges
+10.15M Merger-related fair value of debt instruments
+1.14M Other
= Normalized FFO attributable to common stockholders 143.7M
|
|||
| Normalized FFO attributable to common stockholders per common share - diluted non-GAAP | $0.41 | the three months ended June 30, 2026 filing | — |
| Normalized FFO per common share - diluted non-GAAP | $0.41 | second quarter ended | — |
| Number of markets | 49 | Q2 2026 | — |
| Same store cash NOI non-GAAP | $162.75M | 2Q 2026 | — |
| Same store cash NOI growth | 5.1% | Q2 2026 | — |
| Second quarter lease executions | 1.5M | Q2 2026 | — |
| Secured leverage ratio | 0.2% | 2Q 2026 | — |
| Tenant retention | 88.5% | Q2 2026 | — |
| Total Cash NOI | $170.53M | 2Q 2026 | — |
| Total Properties | 562 | Q2 2026 | — |
| Total shares and OP units outstanding | 346,957,746 | As of June 30, 2026 | — |
| Total Square Feet (in millions) | 32.8M | Q2 2026 | — |
| Unencumbered leverage ratio | 42% | 2Q 2026 | — |
| WALT (in months) | 69 | 2Q 2026 | — |
| WALT (Renewals, in months) | 66.1 | 2Q 2026 | — |
| Weighted average lease term | 5.7 | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HR
this stock
Healthcare Realty Trust Inc
|
$6.54B | +14.0% | -6.9% | — | 5.0% |
|
WELL
Welltower Inc.
|
$179.34B | +31.7% | +35.6% | 106.3 | 2.4% |
|
VTR
Ventas, Inc.
|
$47.02B | +14.9% | +18.5% | 167.8 | 2.8% |
|
OHI
Omega Healthcare Investors Inc
|
$14.32B | +6.1% | +13.2% | 18.9 | 4.8% |
|
DOC
Healthpeak Properties, Inc.
|
$13.78B | +24.3% | +4.5% | 37.0 | 3.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Healthcare Realty Trust Incorporated raised 2026 Normalized FFO guidance to $1.65 to $1.67 per share and Same Store Cash NOI growth guidance to 5.00% to 5.25%. Third-quarter Normalized FFO was $0.42 per share, and the Board approved a $0.24 per share dividend.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HR | +0.6% | +10.5% | -6.0% | +4.5% | +14.0% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -2.0% | +11.7% | -6.5% | +4.7% | +3.4% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
